ANTICANCER ACTIVITY OF TERMINALLIA ARJUNA AGAINST HUMAN CANCER LINE CELLAbstract
In-vitro cytotoxicity testing has become an integral aspect of drug discovery because it is a convenient, cost-effective, and predictive means of characterizing the toxic potential of new chemical entities. The early and routine implementation of this testing is a testament to its prognostic importance for humans. Anticancer activity of different concentrations (20-100) of plant extracts Terminalia arjuna was shown against Hep3-B. MTT [(3, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide)] assay was done in-vitro cytotoxicity test. The low concentration does not show the activities were as extract with 80 μl, and 100 μl concentration showed the activity against Human hepatoma cell line.